John A. Brockman
American Cyanamid
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by John A. Brockman.
Experimental Biology and Medicine | 1957
John A. Brockman; Sherman L. Burson
Summary Extracts of fresh mammalian brain contained substances which inhibited the “slow” closer and opener systems of the crayfish claw. Glutamic acid was one of the substances. Aspartic acid and γ-aminobutyric acid were also active. Glutamic acid had an inhibitory effect and aspartic acid had a stimulatory effect on the crayfish heart.
Experimental Biology and Medicine | 1953
Laurence H. Frommhagen; Marvin J. Fahrenbach; John A. Brockman; E. L. R. Stokstad
Summary Heparin-like polysaccharides with high anticoagulant activity have been isolated from 2 species of clams, Mactra spissula and Artica islandica. These purified polysaccharides, termed mactin-A and mac-tin-B, are related to but not identical with mammalian heparin. They possess a greater in vivo activity and a favorable therapeutic index when compared with heparin preparations of equal in vitro activity.
The Journal of Allergy and Clinical Immunology | 1982
Paul J. Durda; Robert J. Pagano; Norman Bauman; John A. Brockman
The effects of iodipamide on C3 and factor B in normal human serum and in purified form have been examined by immunoelectrophoresis and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Temperature-dependent changes in immunoelectrophoretic profiles have been observed; however, these are not the same as those obtained after treatment of normal human serum (NHS) with cobra venom factor Naja naja. Analyses of iodipamide-treated NHS and purified C3 and factor B by reducing SDS-PAGE indicate that no macromolecular changes have occurred in C3 and factor B that can be ascribed to proteolysis (i.e., activation). The changes observed in C3 and factor B, including loss of hemolytic activity, appear to be due to direct interactions between iodipamide and C3 and factor B. In the case of factor B, iodipamide treatment at 37 degrees C induces aggregation, which is reversible upon reduction with beta-mercaptoethanol.
Journal of Medicinal Chemistry | 1990
Medwid Jb; Rolf Paul; Baker Js; John A. Brockman; Du Mt; William Hallett; Hanifin Jw; Hardy Ra; Tarrant Me; Lawrence Wayne Torley
Journal of Medicinal Chemistry | 1985
Rolf Paul; John A. Brockman; William Hallett; John W. Hanifin; M. Ernestine Tarrant; Lawrence Wayne Torley; Francis M. Callahan; Paul Frank Fabio; Bernard D. Johnson
Archive | 1974
Norman Bauman; John A. Brockman
Journal of Nutrition | 1952
Harry P. Broquist; John A. Brockman; Marvin J. Fahrenbach; E. L. R. Stokstad; T. H. Jukes
Archive | 1971
John A. Brockman
Archive | 1956
John A. Brockman; Roth Barbara
Archive | 1984
Rolf Paul; Robert Allis Hardy; John A. Brockman